hematologic malignancies
Genomic Testing Cooperative Gets UKCA Marks for Cancer Assays
The UK Conformity Assessed marking covers the company's sequencing-based assays for solid tumors and hematologic neoplasms.
NeoGenomics, Adaptive Biotech Partner to Offer Combined Blood Cancer Testing
Doctors ordering NeoGenomics Compass test packages will have the option of including Adaptive's ClonoSeq minimal residual disease assay.
Pathologists See Value Balance Shift Toward Comprehensive Sequencing for Hematologic Cancers
Premium
At the AMP annual meeting last week, speakers at multiple workshops said their field is reaching a tipping point as the clinical utility of NGS further solidifies.
The research hospital is working to further validate and refine its approach, aiming to arm clinicians with a more comprehensive tool to personalize care.
The company is gearing up to launch a new rapid NGS test for acute myeloid leukemia and a liquid biopsy comprehensive genomic profiling assay.
Jan 17, 2024
Mar 12, 2019
Dec 3, 2018
NGeneBio Raises $11M
Apr 26, 2018
Mar 8, 2018